Search Results - Alexis Thompson

P276: Impacts of stigma on adults with thalassemia in the US: Who is impacted and what can we do? by Mallika Venkatramani, Radhika Sawh, Drew Blasco, Alexis Thompson, Beverly Yashar

Get full text

P1442: PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY by Sherif Badawy, Alexis Thompson, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette, Anna Rozova, Janet Kwiatkowski

Get full text

Vimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal Fibrosis. by Paola Bargagna-Mohan, Ling Lei, Alexis Thompson, Camille Shaw, Kousuke Kasahara, Masaki Inagaki, Royce Mohan

Get full text

Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial by John C. Wood, Tara Glynos, Alexis Thompson, Patricia Giardina, Paul Harmatz, Barinder P. Kang, Carole Paley, Thomas D. Coates

Get full text

Cardiac Magnetic Resonance Strain in Beta Thalassemia Major Correlates with Cardiac Iron Overload by Deidra Ansah, Nazia Husain, Alexander Ruh, Haben Berhane, Anthony Smith, Alexis Thompson, Andrew De Freitas, Cynthia K. Rigsby, Joshua D. Robinson

Get full text

Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial by Chris A. Rees, David C. Brousseau, Daniel M. Cohen, Anthony Villella, Carlton Dampier, Kathleen Brown, Andrew Campbell, Corrie E. Chumpitazi, Gladstone Airewele, Todd Chang, Christopher Denton, Angela Ellison, Alexis Thompson, Fahd Ahmad, Nitya Bakshi, Keli D. Coleman, Sara Leibovich, Deborah Leake, Dunia Hatabah, Hagar Wilkinson, Michelle Robinson, T. Charles Casper, Elliott Vichinsky, Claudia R. Morris, the SCD Arginine Study Group and PECARN

Get full text